Why Patients Switch GLP-1 Medications at 1.7mg Dose
Wegovy 1.7 Click Chart: The Switch & Save Advantage
The Wegovy 1.7 click chart represents a critical juncture for patients considering switching from Mounjaro or Ozempic. This dose, administered during weeks 13-16, coincides with when many patients evaluate their treatment's effectiveness and cost sustainability. Patients often discover that switching to Wegovy at this stage can offer both clinical benefits and significant cost savings. The 1.7mg dose allows for a smooth transition while maintaining therapeutic momentum towards your weight management goals.
EverydayMeds uniquely stocks both Wegovy and Mounjaro, enabling seamless switches without changing pharmacy providers. Our clinical team understands the nuances of GLP-1 medication transitions and can guide your switch using the appropriate Wegovy 1.7 click chart protocols. This continuity of care, combined with our competitive pricing structure, makes switching both clinically sound and financially advantageous. The transition timing at 1.7mg is particularly strategic as you're approaching maintenance dosing.
Wegovy 1.7mg Click Chart Pricing & Bundle Value
The Wegovy 1.7 click chart pricing at EverydayMeds reflects our commitment to accessible weight management treatment. Single 1.7mg pens cost £139.99, with returning customers applying code DOSE25 at checkout to achieve this competitive price. For patients planning their transition to maintenance, our Elevate Duo bundle combines 1.7mg and 2.4mg pens for £369.99, providing seamless progression through your final dose escalation. This strategic bundling eliminates supply gaps during your critical transition period.
Patients switching from Mounjaro often discover substantial monthly savings with our Wegovy 1.7 click chart pricing structure. Our Consistency 1.7mg bundle offers two identical pens for £309.99, perfect for patients who need to stabilise at this dose before progressing. The GPhC #9012878 registered pricing ensures transparency and regulatory compliance. New patients switching from other medications can use code FIRST40, while established patients benefit from DOSE25 for continued savings throughout their treatment journey.
Clinical Evidence Supporting Wegovy 1.7 Click Chart Dosing
The Wegovy 1.7 click chart dosing is supported by extensive clinical evidence from the STEP trial programme. Research by Wilding et al., published in NEJM 2021, demonstrated that patients following the complete dose escalation protocol, including the 1.7mg phase, achieved optimal weight management outcomes. The 1.7mg dose represents a critical stepping stone where many patients begin experiencing their most significant results before reaching maintenance therapy.
Clinical data suggests that patients who switch to Wegovy during the 1.7mg phase often maintain treatment continuity more successfully than those switching at lower doses. The STEP trials showed that adherence to the prescribed dose escalation schedule, including the 1.7mg phase, correlates with improved long-term outcomes. This evidence supports the strategic timing of medication switches during the Wegovy 1.7 click chart phase for patients considering treatment optimisation.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1 produced in your intestines. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, promoting feelings of fullness after smaller meals. The medication may also slow gastric emptying, helping you feel satisfied for longer periods after eating. Additionally, Wegovy can reduce food cravings and the preoccupation with food that many patients experience. The once-weekly injection using the convenient FlexTouch pen maintains consistent therapeutic levels, supporting sustainable weight management alongside a reduced-calorie diet and increased physical activity.
Wegovy 1.7 Click Chart Ordering Process
Ordering Wegovy 1.7mg through our streamlined process begins with a comprehensive 3-minute online clinical assessment tailored for patients switching medications. Our qualified prescribers review your current treatment history, including your previous GLP-1 medication experience and dose progression. Standard prescriber review takes 3 working days, though express 24-hour review is available for urgent switches. Once approved, your Wegovy 1.7mg ships via next-day cold-chain delivery, maintaining the strict temperature control required for this prescription-only medicine. Our GPhC #9012878 registered service ensures full regulatory compliance throughout the switching process.
Storage & Practical Considerations for Wegovy 1.7mg
The Wegovy 1.7 click chart includes specific storage requirements that offer advantages over some competing medications. Store unopened pens in the refrigerator at 2-8°C, though once removed, Wegovy can remain at room temperature below 30°C for up to 6 weeks. This extended room temperature stability provides superior travel convenience compared to Mounjaro's 21-day limit. Each FlexTouch pen delivers the precise 1.7mg dose with an audible click confirmation, ensuring accurate dosing. The dose escalation protocol requires completing the full 4-week cycle at 1.7mg before progressing to the 2.4mg maintenance dose, making adherence to the Wegovy 1.7 click chart schedule essential for optimal outcomes.
Strategic Switching: Why 1.7mg is the Optimal Transition Point
The Wegovy 1.7 click chart phase represents the optimal switching window for patients transitioning from other GLP-1 medications. At this dose level, patients have typically adapted to injectable therapy and developed sustainable administration routines, reducing the risk of treatment discontinuation during the switch. The 1.7mg dose also coincides with when many patients experience their most noticeable appetite suppression effects, making it psychologically easier to maintain treatment continuity. Switching at this strategic point allows patients to capitalise on their established momentum while optimising their medication costs.
Clinical experience suggests that patients switching to Wegovy during the 1.7mg phase often report smoother transitions compared to earlier dose switches. The dose equivalency between GLP-1 medications at this level provides prescribers with clearer switching protocols, reducing the risk of under- or over-dosing during transition. EverydayMeds' expertise in managing both Wegovy and Mounjaro supplies ensures your switch occurs seamlessly without treatment interruption, maximising the benefits of your strategic timing decision.
Complete Your Switch: Next-Day Wegovy 1.7mg Delivery
Ready to switch to Wegovy 1.7mg and start saving? Our streamlined process ensures your transition happens quickly and safely, with expert clinical oversight throughout. Use code DOSE25 at checkout to achieve our competitive £139.99 pricing, or consider the Elevate Duo bundle for seamless progression to maintenance dosing. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and secure next-day delivery. Our cold-chain logistics assurance your medication arrives in perfect condition, ready to continue your weight management journey. Trust EverydayMeds' GPhC #9012878 registered service to make your medication switch both cost-effective and clinically sound, with ongoing support from our experienced team.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
